IL17A and prostate carcinoma: However, in patients with distant metastasis of prostate cancer, we found a significant increase in IL-17A levels; while, levels of cytokines IL-2, IL-4, IL-10, TNF-a, IFN-γ, IL-1β, and IL-12P70 were significantly decreased (As show in Table 2).